托菲尔Tofer品牌怎么样 申请店铺

我要投票 托菲尔Tofer在婴儿奶粉行业中的票数:229 更新时间:2025-04-02
托菲尔Tofer是哪个国家的品牌?「托菲尔Tofer」是 内蒙古伊利实业集团股份有限公司 旗下著名品牌。该品牌发源于内蒙古,由创始人潘在1993-06-04期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力托菲尔Tofer品牌出海!通过在本页面挂载托菲尔Tofer品牌的产品链接和联系邮箱,可以提高托菲尔Tofer产品曝光!跨境电商爆单神器,目前只要100元/年哦~

托菲尔Tofer怎么样

托菲尔是伊利集团旗下独立运营的子品牌,托菲尔系统的配方、高端的产品定位、雄厚的国际研究背景,率先为其占据市场份额打出一记“高效组合拳”。其融合创新科技的蛋白酶水解技术与欧洲百年BID复合益生菌科研成果技术,将系统解决食用奶粉过程中婴幼儿胃肠道舒适度问题,全面降低胃肠道消化负担,提升营养吸收率及免疫应答,建立完善的舒适屏障.

作为伊利全球化战略的首批践行者,托菲尔新品的问世不得不让人惊奇。它的出现,充分说明中国乳企对自身未来发展的准确定位以及对国际乳粉行业的精准判断。通过与国际上优秀的行业研究机构的合作与交流,取长补短,达成双赢,切实践行国际化战略理想。这一方面反映出伊利作为国内乳业巨头的不俗实力,另一方面也反映出伊利在乳制品全产业链建设方面所作出的不懈努力.

托菲尔的专家们进行了大量详实而又细致的消费者调查。结果显示,许多妈妈对于宝宝的无端哭闹显出诸多困扰与无奈,迫切希望能够尽早解决这一难题。经过伊利欧洲研发中心与众多著名生命科学及营养研究机构共同研究发现,婴幼儿在饮食过程中,摄入的蛋白分子较大,一方面不容易被消化吸收,另一方面,这些“大号”蛋白分子中夹杂着许多过敏原,加之婴幼儿肠道系统的自身屏障作用又很弱,无法有效隔离难消化的大分子物质和有害物质,从而导致肠胃不适,进而会影响宝宝成长发育。

托菲尔舒适配方即针对宝宝胃肠道不适问题应运而生。其融合创新科技的蛋白酶水解技术,使蛋白小分子更容易渗透到宝宝体内被消化吸收,降低过敏发生风险23%,致敏性大大降低。同时降低胃肠道消化负担,减少宝宝哭闹时间,全面提升营养吸收率。而其融合欧洲百年益生菌科研成果技术的BID®复合益生菌,能稳定定植于肠道的上、下段部位,促进肠壁细胞间的结构更加紧密,从而阻止有害物质侵入宝宝身体,防止腹泻和消化道感染,提升肠道免疫应答,建立完善的肠道舒适屏障。


TOEFL is an independent sub brand of Yili Group. With its formulation, high-end product positioning and strong international research background, TOEFL takes the lead in making a "high-efficiency combination fist" for its market share. With the combination of the innovative protease hydrolysis technology and the research achievement technology of European bid composite probiotics, it will systematically solve the gastrointestinal comfort problem of infants in the process of eating milk powder, comprehensively reduce the burden of gastrointestinal digestion, improve the nutritional absorption rate and immune response, and establish a perfect comfort barrier. As the first practitioner of Yili's globalization strategy, TOFEL's new product will not come out It's not surprising. Its emergence fully shows that China's dairy enterprises have accurate positioning for their future development and accurate judgment for the international dairy industry. Through the cooperation and exchange with international excellent industry research institutions, we can learn from each other's strengths and make up for each other's weaknesses, achieve a win-win situation, and earnestly practice the international strategic ideal. On the one hand, it reflects Erie's great strength as a domestic dairy giant, on the other hand, it also reflects Erie's unremitting efforts in the construction of the whole dairy industry chain. TOFEL's experts conducted a large number of detailed and detailed consumer surveys. The results show that many mothers show a lot of troubles and helplessness for their babies' unreasonable crying, and they are eager to solve this problem as soon as possible. Through the joint research of Erie European research and development center and many famous life science and nutrition research institutions, it is found that the protein molecules consumed by infants and young children in the diet process are large, on the one hand, they are not easy to be digested and absorbed, on the other hand, these "large" protein molecules are mixed with many allergens, on the other hand, the self barrier function of infant intestinal system is weak, so they cannot be effectively isolated Indigestible macromolecular substances and harmful substances lead to gastrointestinal discomfort, which will affect the growth and development of baby. TOFEL comfort formula is designed for gastrointestinal discomfort. The protease hydrolysis technology, which integrates innovative technology, makes the protein molecules more easily penetrate into the baby's body and be digested and absorbed, reduces the risk of allergy by 23%, and greatly reduces the allergenicity. At the same time, it can reduce the burden of gastrointestinal digestion, reduce the crying time of the baby, and comprehensively improve the nutritional absorption rate. The bid ® composite probiotics, which integrates the research achievements of European probiotics for one hundred years, can be stably planted in the upper and lower parts of the intestinal tract, promote the closer structure of intestinal wall cells, so as to prevent harmful substances from invading the baby's body, prevent diarrhea and digestive tract infection, improve the intestinal immune response, and establish a perfect intestinal comfortable barrier.

本文链接: https://brand.waitui.com/099c6971e.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

今年一季度A股新开户747万户,同比增长31.74%

36氪获悉,4月2日,上交所披露,今年3月A股新开户数据306.55万户,环比继续快速增长。数据显示,今年1月、2月和3月A股新开户数分别为157万户、283.59万户和306.55万户。今年3月新增开户数306.55万户,较2024年3月新开户数242万户同比增长26.67%。

2分钟前

国信证券:获批发行不超200亿元永续次级债券

36氪获悉,国信证券公告,近日收到中国证监会出具的批复,同意公司向专业投资者公开发行面值总额不超过200亿元永续次级债券的注册申请。批复自同意注册之日起24个月内有效,公司在注册有效期内可以分期发行永续次级公司债券。公司将按照有关法律法规和上述批复文件要求及公司股东大会的授权办理永续次级债券发行的相关事宜,并及时履行信息披露义务。

2分钟前

华为哈勃入股成都芯曌科技,后者含电子专用材料研发等业务

36氪获悉,天眼查App显示,近日,成都芯曌科技有限公司发生工商变更,新增华为旗下深圳哈勃科技投资合伙企业(有限合伙)为股东,注册资本由6213万人民币增至约7020万人民币,同时,部分高管发生变更。成都芯曌科技有限公司成立于2019年10月,法定代表人为朱荣,经营范围含电子专用材料研发、电子专用材料制造、电子专用材料销售、集成电路设计、电子元器件制造等。股东信息显示,该公司现由成都大超科技有限公司、朱荣及上述新增股东共同持股。

2分钟前

恒润股份:公司基本面未发生重大变化

36氪获悉,恒润股份发布股票交易风险提示公告,公司股票股价短期涨幅较大,存在一定风险。公司基本面未发生重大变化,也不存在应披露而未披露的重大信息。敬请广大投资者注意二级市场交易风险,理性决策,审慎投资。

2分钟前

立讯精密被曝正考虑赴港上市?官方不予置评

日前,有消息称,有知情人士透露立讯精密考虑今年在香港上市,目前正与投行商讨赴港上市事宜,初步预计融资规模为20亿至30亿美元。不过,知情人士也提醒,立讯精密赴港上市规模尚未最终确定,将取决于市场情况。对此,立讯精密表示,不予置评。

2分钟前

本页详细列出关于FIRMUS飞鹤的品牌信息,含品牌所属公司介绍,FIRMUS飞鹤所处行业的品牌地位及优势。
咨询